Clinical Experience with High-Dose Polymyxin B against Carbapenem-Resistant Gram-Negative Bacterial Infections—A Cohort Study

Population pharmacokinetic studies have suggested that high polymyxin B (PMB) doses (≥30,000 IU/kg/day) can improve bacterial kill in carbapenem-resistant Gram-negative bacteria (CR-GNB). We aim to describe the efficacy and nephrotoxicity of patients with CR-GNB infections prescribed high-dose PMB....

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Yiying, Leck, Hui, Tan, Ray W., Teo, Jocelyn Q., Lim, Tze-Peng, Lee, Winnie, Chlebicki, Maciej Piotr, Kwa, Andrea L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7459528/
https://www.ncbi.nlm.nih.gov/pubmed/32726974
http://dx.doi.org/10.3390/antibiotics9080451

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7459528/
https://www.ncbi.nlm.nih.gov/pubmed/32726974
http://dx.doi.org/10.3390/antibiotics9080451

Ejemplares similares